$LQDA

Khindri Sanjeev sold $271K of LQDA

Khindri Sanjeev (Chief Development Officer) sold 4,134 shares of Liquidia Corp (LQDA) at $65.46 ($0.27M total) on 2026-06-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Khindri Sanjeev
Published Jun 10, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

The disclosure adds incremental information about insider liquidity/positioning but does not introduce new company fundamentals (no guidance, trial results, or regulatory actions).

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing is unlikely to drive a major repricing without additional catalysts.

03

What to watch

The article lacks context on total insider activity, prior sales cadence, and whether the sale was for diversification/tax—so the signal-to-noise is low.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-10; transaction dated 2026-06-08.

Background

The article is an SEC Form 4 insider transaction disclosure for Liquidia Corp.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia Corp (LQDA) disclosed an insider open-market sale by CDO Khindri Sanjeev: 4,134 shares sold at $65.46 on 2026-06-08 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, which typically reduces interpretive value; the article provides no new operational/clinical/regulatory catalyst.

Market effects

Minimal; single-company insider sale without new sector/regulatory developments.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with management’s view of near-term risk; traders may use it as a sentiment check rather than a fundamental signal.

Key entities

  • Liquidia Corp

    Subject of the Form 4 insider transaction disclosure.

  • Khindri Sanjeev

    Chief Development Officer who sold shares under a pre-arranged 10b5-1 plan.

Related articles

$LQDAMedAI 8/10

Liquidia (NASDAQ:LQDA) Shares Up 14.9% – What’s Next?

Liquidia (NASDAQ:LQDA) shares rose 14.9% to about $64 in mid-day trading Thursday after closing at $55.69; the stock traded as high as $62.20 on lighter volume (779,911 shares vs. 1.67M average). The May 11 quarter beat estimates: EPS $0.52 vs. $0.41; revenue $132.87M vs. $119.44M. Analysts’ targets ranged from $19 to $70.